The indices displayed on this map are a measure of the concentration of firms at the national level for a given emerging industry and indicator (selected in the left hand menu). The indices are location quotients and they compare, for the selected segment and emerging industry, the proportion of firms in the emerging industry in each country over the total number of firms for all emerging industries in the same country, to the proportion of firms in the emerging industry across Europe over the total number of firms in all emerging industries in Europe. Values below 1 indicate that the country has a lower concentration of firms for a given segment and emerging industry compared to the average concentration of firms for this emerging industry across Europe. Values above 1 indicate that the country has an above average concentration of firms for the segment.

Country Details

Area NameCodeValue
Austria AT
Belgium BE
Bulgaria BG
Cyprus CY
Czech Republic CZ
Denmark DK
Estonia EE
Finland FI
France FR
Germany DE
Greece GR
Hungary HU
Ireland IE
Italy IT
Latvia LV
Lithuania LT
Luxembourg LU
Malta MT
Netherlands NL
Poland PL
Portugal PT
Romania RO
Slovakia SK
Slovenia SI
Spain ES
Sweden SE
United Kingdom UK


The methodology for the creation of these maps is detailed in the methodologies section of the website.

Defining Personalised medicine

Personalised medicine industries comprise activities designed to supply innovative products and services in the fields of medical technology, medical and surgical equipment and devices, Personalised Medicine information technology, Personalised Medicine infrastructure and services, clinical trials, as well as preventative Personalised Medicine care and general well-being (natural Personalised Medicine care, sport and recreation, community services, Personalised Medicine information, Personalised Medicine homes).

These industries combine the fields of science, engineering and technologies to facilitate new innovations in the biomedical sphere and an increasing convergence of physical and biological technology platforms. They are key to supporting breakthroughs in medical knowledge and technologies, addressing major Personalised Medicine and societal challenges (such as the threat of new diseases, pandemics or ageing), enabling greater choice and the customisation of Personalised Medicine care (personalised medicine) and a move towards new Personalised Medicine lifestyles.

For further details, please see the personalised medicine definition page in the methodologies section of the website.